Label: ANACIN- asprin and caffeine tablet
-
NDC Code(s):
63736-200-04,
63736-200-30,
63736-200-50,
63736-200-90, view more63736-200-91, 63736-200-92, 63736-200-93, 63736-200-95
- Packager: Insight Pharmaceuticals LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated July 2, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients (per tablet)
- Purposes
- Uses
-
Warnings
Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Allergy alert:
Aspirin may cause a severe allergic reaction which may include:
- hives
- facial swelling
- asthma (wheezing)
- shock
Stomach bleeding warning
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
- are age 60 or older
- have had stomach ulcers or bleeding problems
- take a blood thinner (anticoagulant) or steroid drug
- take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
- have 3 or more alcoholic drinks every day while using this product
- take more or for a longer time than directed
Ask a doctor before use if
- stomach bleeding warning applies to you
- you have a history of stomach problems, such as heartburn
- you have high blood pressure, heart disease, liver cirrhosis, or kidney disease you are taking a diuretic
- you have asthma
Ask a doctor or pharmacist before use if
you are taking a prescription drug for diabetes, gout, or arthritis
Stop use and ask a doctor if
- an allergic reaction occurs. Seek medical help right away.
- you experience any of the following signs of stomach bleeding
- feel faint
- vomit blood
- have bloody or black stools
- have stomach pain that does not get better
- feel faint
- new symptoms occur
- ringing in the ears or loss of hearing occurs
- redness or swelling is present
- pain gets worse or lasts more than 10 days
- fever gets worse or lasts more than 3 days
Caffeine warning
The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat.
- hives
-
Directions
-
do not use more than directed (see overdose warning)
- drink a full glass of water with each dose
- adults and children 12 years of age and older: take 2 tablets every 6 hours; not more than 8 tablets in 24 hours, or as directed by a doctor
- children under 12 years of age: do not use
-
do not use more than directed (see overdose warning)
- Inactive ingredients
- Questions?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ANACIN
asprin and caffeine tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63736-200 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN 400 mg CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE 32 mg Inactive Ingredients Ingredient Name Strength HYPROMELLOSES (UNII: 3NXW29V3WO) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) SODIUM LAURYL SULFATE (UNII: 368GB5141J) STARCH, CORN (UNII: O8232NY3SJ) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) Product Characteristics Color WHITE Score no score Shape ROUND Size 10mm Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63736-200-04 1 in 1 BOX 06/25/2009 06/30/2023 1 4 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:63736-200-93 1 in 1 BOX 06/25/2009 2 300 in 1 BOTTLE; Type 0: Not a Combination Product 3 NDC:63736-200-30 1 in 1 BOX 06/25/2009 06/30/2023 3 30 in 1 BOTTLE; Type 0: Not a Combination Product 4 NDC:63736-200-50 1 in 1 BOX 06/25/2009 4 50 in 1 BOTTLE; Type 0: Not a Combination Product 5 NDC:63736-200-90 1 in 1 BOX 06/25/2009 5 100 in 1 BOTTLE; Type 0: Not a Combination Product 6 NDC:63736-200-91 1 in 1 BOX 06/25/2009 06/30/2023 6 130 in 1 BOTTLE; Type 0: Not a Combination Product 7 NDC:63736-200-92 125 in 1 BOX 06/25/2009 7 1 in 1 POUCH; Type 0: Not a Combination Product 8 NDC:63736-200-95 750 in 1 BOX 06/25/2009 06/30/2023 8 1 in 1 POUCH; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part343 06/25/2009 Labeler - Insight Pharmaceuticals LLC (055665422)